How much is Quell Therapeutics worth in 2026?

Quell Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Quell Therapeutics raised?

Quell Therapeutics has raised N/A in total funding across 1 funding rounds.

Quell Therapeutics

Drug Discovery

Quell Therapeutics valuation and funding history | Last updated: November 24, 2021 | 1 funding rounds

Current Valuation

N/A

As of November 24, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$156.0M

Last Funding

Nov 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 24, 2021	Early Stage VC (Series B)	$156.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Quell Therapeutics is currently valued at N/A as of November 24, 2021.

Track Quell Therapeutics Valuation Updates

Get notified when Quell Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Quell Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Quell Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Quell Therapeutics Worth in 2026?

Quell Therapeutics is a leading private company in the Drug Discovery sector. Track Quell Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Quell Therapeutics Valuation is Determined

Private company valuations like Quell Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.